These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 11984703

  • 1. Screening for gastric cancer in Japan.
    Tsubono Y, Hisamichi S.
    Gastric Cancer; 2000 Aug 04; 3(1):9-18. PubMed ID: 11984703
    [Abstract] [Full Text] [Related]

  • 2. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.
    Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Tanaka S, Kajiyama G, Shigenobu T.
    Hiroshima J Med Sci; 1997 Jun 04; 46(2):81-6. PubMed ID: 9232936
    [Abstract] [Full Text] [Related]

  • 3. Screening for Gastric Cancer in Miyagi, Japan: Evaluation with a Population-Based Cancer Registry.
    Tsubono Y, Nishino Y, Tsuji I, Hisamichi S.
    Asian Pac J Cancer Prev; 2000 Jun 04; 1(1):57-60. PubMed ID: 12718689
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The Japanese guidelines for gastric cancer screening.
    Hamashima C, Shibuya D, Yamazaki H, Inoue K, Fukao A, Saito H, Sobue T.
    Jpn J Clin Oncol; 2008 Apr 04; 38(4):259-67. PubMed ID: 18344316
    [Abstract] [Full Text] [Related]

  • 6. Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan.
    Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S, JPHC Study Group.
    Int J Cancer; 2006 May 01; 118(9):2315-21. PubMed ID: 16331632
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality.
    Jun JK, Choi KS, Lee HY, Suh M, Park B, Song SH, Jung KW, Lee CW, Choi IJ, Park EC, Lee D.
    Gastroenterology; 2017 May 01; 152(6):1319-1328.e7. PubMed ID: 28147224
    [Abstract] [Full Text] [Related]

  • 8. [Evaluation on a gastric mass survey-comparison with gastric mass screening using photofluorography and that using serum pepsinogen].
    Tomooka Y.
    Nihon Koshu Eisei Zasshi; 1996 Feb 01; 43(2):118-25. PubMed ID: 8901216
    [No Abstract] [Full Text] [Related]

  • 9.
    Movik E, Dalsbø TK, Fagelund BC, Friberg EG, Håheim LL, Skår Å.
    ; 2017 09 04. PubMed ID: 29553669
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of cutoff levels for screening of gastric cancer using serum pepsinogens and distributions of levels of serum pepsinogen I, II and of PG I/PG II ratios in a gastric cancer case-control study.
    Aoki K, Misumi J, Kimura T, Zhao W, Xie T.
    J Epidemiol; 1997 Sep 04; 7(3):143-51. PubMed ID: 9337512
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    Wernli KJ, Henrikson NB, Morrison CC, Nguyen M, Pocobelli G, Whitlock EP.
    ; 2016 07 04. PubMed ID: 27583318
    [Abstract] [Full Text] [Related]

  • 13.
    Fenton JJ, Weyrich MS, Durbin S, Liu Y, Bang H, Melnikow J.
    ; 2018 05 04. PubMed ID: 30085502
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study.
    Yoshihara M, Hiyama T, Yoshida S, Ito M, Tanaka S, Watanabe Y, Haruma K.
    Scand J Gastroenterol; 2007 Jun 04; 42(6):760-4. PubMed ID: 17505999
    [Abstract] [Full Text] [Related]

  • 17. Screening of gastric cancer in Asia.
    Sugano K.
    Best Pract Res Clin Gastroenterol; 2015 Dec 04; 29(6):895-905. PubMed ID: 26651251
    [Abstract] [Full Text] [Related]

  • 18.
    Melnikow J, Henderson JT, Burda BU, Senger CA, Durbin S, Soulsby MA.
    ; 2018 08 04. PubMed ID: 30256575
    [Abstract] [Full Text] [Related]

  • 19. [Pepsinogen].
    Miki K.
    Nihon Rinsho; 1995 May 04; 53(5):1198-202. PubMed ID: 7602778
    [Abstract] [Full Text] [Related]

  • 20. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer.
    Miki K, Ichinose M, Ishikawa KB, Yahagi N, Matsushima M, Kakei N, Tsukada S, Kido M, Ishihama S, Shimizu Y.
    Jpn J Cancer Res; 1993 Oct 04; 84(10):1086-90. PubMed ID: 8226283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.